With U.S. Health Systems Under Growing Pressure to Fill Staff Vacancies, CGFNS Alliance Releases Updated Standards for Ethical Recruitment of Foreign Health Workers
Mar 07, 2023 13:30 HKT |  |
|
EC Healthcare Opened the First Organic Flagship Veterinary Hospital in Hong Kong
Mar 06, 2023 15:50 HKT |  |
|
Prenetics Announces Formation of Scientific Advisory Board to Support New Business Strategy in Precision Oncology
Mar 04, 2023 15:40 HKT |  |
|
CATALIST-listed AOXIN Q&M reports lower revenue of RMB 140m for full year ended 31 December 2022
Mar 03, 2023 08:00 HKT |  |
|
Q&M reports lower full year profits due to impairments and decrease in Covid-19 related revenue
Mar 01, 2023 23:00 HKT |  |
|
Kingworld Medicines Earns "Shenzhen Time-honored Brand" Title Again
Feb 28, 2023 15:03 HKT | |
|
Malaysian Genomics Pivots to Biopharmaceuticals for Growth
Feb 24, 2023 17:30 HKT |  |
|
Lepu Biopharma and Keymed Jointly Announces Global Exclusive Licence Agreement with AstraZeneca for CMG901
Feb 23, 2023 10:18 HKT | |
|
Essex and Henlius signed amendment agreement for Global Co-Development and Exclusive License Agreement for treatment of age-related macular degeneration
Feb 22, 2023 18:48 HKT |  |
|
Malaysian Genomics to Offer World's First DNA-Driven Fertility Test
Feb 22, 2023 14:30 HKT | |
|
Led by Legend Capital, Macrolux Completes Nearly CNY100 million Series A Round
Feb 16, 2023 17:09 HKT |  |
|
Innovation is the Key Benchmark, Focus on Four Healthcare Industry Sub-Sectors in 2023, Says Jafar Wang of Legend Capital
Feb 15, 2023 18:58 HKT | |
|
The Evolving Global Landscape in Vaccine Development: Novotech and Endpoints News Webinar
Feb 15, 2023 09:00 HKT |  |
|
ONERHT Foundation together with Chui Huay Lim Club and Ee Hoe Hean Club raise close to S$500,000 to promote medical care and support for disadvantaged groups
Feb 14, 2023 17:00 HKT |  |
|
Ocumension Therapeutics Issues Positive Profit Alert for 2022 Annual Results
Feb 14, 2023 10:57 HKT |  |
|
EC Healthcare Announced Strategic Alliance with Prudential
Feb 13, 2023 19:09 HKT | |
|
First Patient in the US Dosed in a Global Multicentre Phase 3 Clinical Study of Bevacizumab for treatment of Ophthalmic Diseases
Feb 10, 2023 21:06 HKT | |
|
Novotech Global Report: Robust Phase 1 Trial Growth Across Asia Pacific
Feb 10, 2023 19:00 HKT | |
|
Asia Pacific Cell & Gene Research Growing 50% Faster than ROW
Feb 03, 2023 13:00 HKT | |
|
Ocumension Therapeutics Announces The Completion Of The Phase I Clinical Trial Of Its Class I New Drug For The Treatment Of Dry Eye -- OT-202
Feb 03, 2023 10:01 HKT | |
|